Timothy Caulfield’s article, “Microbiome research needs a gut check” published in the Globe and Mail, reminds us of just where we’re at in researching the microbiome – the vast array of bacteria, fungi, protozoa and viruses that live on and inside the human body. “Gut hype is everywhere” says Caulfield, who is one of many voices cautioning about over simplistic…
Read More
Decipher Biosciences (formerly GenomeDx), a leader in the field of urologic cancer genomics, has announced a research collaboration with Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, to apply genomic tumor profiling using the Decipher® assay and GRID® software to identify prostate cancer patients on active surveillance who may benefit most from treatment with sipuleucel-T. PROVENGE®…
Read More
Robert Hogg has been appointed as the new Associate Dean, Research in the Faculty of Health Sciences (FHS). Hogg will lead the ongoing implementation of FHS’s strategic research plan and oversee various research projects and initiatives in each of the faculty’s six major research challenge areas. “I am excited to have Bob join the FHS leadership team,” says FHS dean Tania…
Read More
The University of British Columbia and the University of Oxford have formalized a transatlantic partnership that will create a global network for training in clinical pharmacology. (L to R): Dr. Sultan Karim, Professor John Climax, and Dr. Dermot Kelleher UBC and Oxford have signed a memorandum of understanding to create a pathway for the exchange of people and ideas to…
Read More

Joining Forces For Responsive And Responsible Research Funding

As BC’s health research funding agency, we think deeply about how to grow, improve and best support BC health research. Since our first Forward Thinking post, we’ve shared a series of blogs on health research funding and ‘helping-it-happen’. In this post, MSFHR’s President & CEO Dr. Bev Holmes discusses a new collaboration with like-minded funders to further research-on-research and maximize our investments. Forward Thinking is MSFHR’s blog focusing…
Read More
Measuring the levels of insulin-like growth factor 2 receptor (IGF2R) during the first days of treatment with intravenous antibiotics could help predict treatment response in cystic fibrosis patients experiencing pulmonary exacerbations, a study has found. The study, “Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics,” was published in the journal Nature Scientific Reports. Pulmonary exacerbations are frequent among people…
Read More
Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, is pleased to announce a collaboration with global biopharmaceutical company AstraZeneca, in an effort to develop the world’s first human-specific in vitro, functional model of heart failure with preserved ejection fraction (HFpEF), a common condition especially among the elderly and in women, with the reported prevalence approaching…
Read More
The recent announcement that an experimental Alzheimer’s drug is being resurrected after it was previously deemed a failure has made international headlines. Last month, biotech company Biogen said it would seek U.S. market approval for aducanumab, which, if approved, would become the first therapy to reduce the clinical decline of Alzheimer’s disease. The news came as a surprise to many. Last March,…
Read More
I’m pleased to announce the renewal and expansion of our Collaborative Research Mobility Awards (CRMA) program, a program which helps our research community establish new, or expand on existing, collaborations. The CRMA program facilitates collaboration on timely research opportunities between researchers in Vancouver and the Okanagan, helping them share knowledge, interests and access to equipment. These competitions are now running quarterly and have in…
Read More
A competition designed by MIT, international genetically engineered machinery (iGEM) is where teams across the globe develop a biosensor to solve modern issues from scratch over the summer. At iGEM’s Giant Jamboree in Boston that ran from October 31 to November 4, UBC’s team won two golds for their Paralyte-STX project. “It felt surreal to actually get the news,” said…
Read More